ARS Pharmaceuticals

SPRY

NASDAQHealth Care

Income Statement

Total Revenue$89.15M

Gross Profit$88.17M

Operating Income$-3.08M

EBITDA$8.37M

EBIT$8.29M

Pre-tax Income$-171.38M

Net Income$8M

Cash Equivalent$45.78M

Total Debt$17.48M

Book Value$224.22M

Book Value Per Share2.31

Return on Equity (ROE)+3.11%

Return on Assets (ROA)+2.28%

Return on Invested Capital (ROI)+3.11%

Net Profit Margin+8.97%

Current Ratio14.26

Quick Ratio13.84

Long-Term Debt / Equity0.00